top of page

CLIENT IN THE NEWS

Exclusive: Myeloid Therapeutics moves second in vivo cell therapy into trials, targeting liver cancer

ENDPTS.COM

Synthego announces CEO Transition for Enabling CRISPR Therapeutics

AI-TECHPARK.COM

Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform

GENENGNEWS.COM

Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance

PRNEWSWIRE.COM

Synthego, bit.bio Collaborate on Multiplexed Cell Engineering Platform

GENENGNEWS.COM

Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors

MYELOIDTX.COM

Synthego Opens GMP RNA Manufacturing Facility

TECHSCIRESEARCH.COM

Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline

MYLOIDTX.COM

Kaléo Expands Executive Team to Support Growth

KALEO.COM

Myeloid raises funds to support lead cell therapy programme

PHARMACEUTICAL-TECHNOLOGY.COM

Adaptimmune & TCR2 Combine in Marriage of Cell Therapy

MEDCITYNEWS.COM

Myeloid Therapeutics Goes Down Under for mRNA Manufacturing

ENDPTS.COM

bottom of page